HS Research As outlined here and here, research in HS has grown considerably in recent years, contributing to: Improved understanding of the disease Increased awareness Development of new treatment approaches Greater recognition of patient experiences and priorities Partnering in Research Progress in HS research depends on collaboration between many different groups, including but not limited to: People living with HS Researchers Clinicians Nurses and study teams Patient organisations HS Ireland is committed to partnering with others in advancing HS research, as outlined here
View Chemical Reference Data (PubChem)
Every patient responds differently, and factors like your starting dose, dosage adjustments, lifestyle, and unique body chemistry can influence how quickly you see results
Wegovy Pill dosing chart: Complete titration schedule (2026) The Wegovy pill follows a four-phase titration schedule, starting at 1.5 mg and reaching 25 mg over approximately 3 months
If you dont see adequate improvement by week 12, your practitioner can adjust the dose or explore alternatives depending on your symptoms of anxiety